Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NRIX |
---|---|---|
09:32 ET | 6402 | 15.825 |
09:34 ET | 1846 | 15.8 |
09:36 ET | 100 | 15.825 |
09:38 ET | 100 | 15.77 |
09:41 ET | 1142 | 15.615 |
09:43 ET | 955 | 15.5 |
09:45 ET | 100 | 15.565 |
09:52 ET | 1600 | 15.43 |
09:54 ET | 400 | 15.53 |
09:56 ET | 200 | 15.5 |
09:57 ET | 100 | 15.59 |
10:01 ET | 400 | 15.56 |
10:03 ET | 400 | 15.55 |
10:06 ET | 500 | 15.51 |
10:08 ET | 587 | 15.4 |
10:10 ET | 100 | 15.39 |
10:12 ET | 300 | 15.405 |
10:17 ET | 508 | 15.495 |
10:19 ET | 46856 | 15.4 |
10:21 ET | 2375 | 15.46 |
10:24 ET | 439 | 15.46 |
10:26 ET | 400 | 15.43 |
10:28 ET | 500 | 15.52 |
10:30 ET | 507 | 15.565 |
10:33 ET | 1620 | 15.55 |
10:35 ET | 614 | 15.58 |
10:37 ET | 100 | 15.55 |
10:39 ET | 4060 | 15.54 |
10:42 ET | 1311 | 15.47 |
10:46 ET | 1100 | 15.43 |
10:50 ET | 582 | 15.385 |
10:51 ET | 359 | 15.425 |
10:57 ET | 1016 | 15.37 |
11:02 ET | 1703 | 15.28 |
11:04 ET | 100 | 15.29 |
11:06 ET | 304 | 15.295 |
11:08 ET | 100 | 15.32 |
11:09 ET | 656 | 15.355 |
11:11 ET | 200 | 15.38 |
11:13 ET | 100 | 15.381 |
11:18 ET | 1077 | 15.38 |
11:22 ET | 256 | 15.405 |
11:24 ET | 5746 | 15.47 |
11:26 ET | 200 | 15.475 |
11:27 ET | 1040 | 15.5 |
11:29 ET | 1049 | 15.46 |
11:31 ET | 800 | 15.5 |
11:33 ET | 100 | 15.52 |
11:36 ET | 100 | 15.55 |
11:38 ET | 558 | 15.54 |
11:40 ET | 300 | 15.51 |
11:44 ET | 100 | 15.52 |
11:45 ET | 966 | 15.515 |
11:47 ET | 800 | 15.47 |
11:49 ET | 100 | 15.475 |
11:51 ET | 256 | 15.485 |
11:54 ET | 485 | 15.47 |
11:56 ET | 1063 | 15.43 |
12:00 ET | 200 | 15.46 |
12:02 ET | 100 | 15.43 |
12:03 ET | 2353 | 15.47 |
12:07 ET | 1166 | 15.52 |
12:09 ET | 282 | 15.58 |
12:12 ET | 254 | 15.57 |
12:14 ET | 200 | 15.6 |
12:16 ET | 6327 | 15.5 |
12:18 ET | 1257 | 15.48 |
12:23 ET | 101 | 15.4525 |
12:25 ET | 750 | 15.4342 |
12:27 ET | 100 | 15.48 |
12:30 ET | 1156 | 15.46 |
12:32 ET | 361 | 15.45 |
12:34 ET | 300 | 15.46 |
12:39 ET | 300 | 15.4414 |
12:43 ET | 1185 | 15.445 |
12:45 ET | 200 | 15.43 |
12:48 ET | 114 | 15.46 |
12:50 ET | 200 | 15.49 |
12:52 ET | 200 | 15.44 |
12:54 ET | 982 | 15.44 |
12:56 ET | 300 | 15.47 |
12:57 ET | 100 | 15.46 |
12:59 ET | 700 | 15.42 |
01:01 ET | 200 | 15.42 |
01:08 ET | 200 | 15.43 |
01:10 ET | 354 | 15.43 |
01:12 ET | 100 | 15.42 |
01:14 ET | 200 | 15.43 |
01:15 ET | 300 | 15.45 |
01:17 ET | 1000 | 15.45 |
01:19 ET | 1233 | 15.44 |
01:21 ET | 712 | 15.42 |
01:26 ET | 461 | 15.36 |
01:28 ET | 2476 | 15.335 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nurix Therapeutics Inc | 942.9M | -5.8x | --- |
Regenxbio Inc | 796.0M | -2.7x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -2.4x | --- |
CureVac NV | 715.5M | -2.7x | --- |
SAGE Therapeutics Inc | 704.7M | -1.4x | --- |
Zymeworks Inc | 646.9M | -5.2x | --- |
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $942.9M |
---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.18 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | 11.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.